4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 18, 2020 at 12:22 PM.

  1. #1 cafead, Nov 18, 2020 at 12:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,989
    Likes Received:
    3
    via Just a few months after withdrawing its IPO filing, 4D Molecular Therapeutics is seeking to go public once again.

    The Emeryville, CA-based company submitted a new S-1 on Tuesday, detailing plans for a $75 million raise as it aims for the second time to hit the Nasdaq. 4DMT had previously sought a $100 million IPO back in September 2019, but withdrew the filing in July of this year after completing a $75 million Series C in June.

    article source
     
    Quote

Reply to Thread